0000899243-22-010794.txt : 20220311 0000899243-22-010794.hdr.sgml : 20220311 20220311210013 ACCESSION NUMBER: 0000899243-22-010794 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220310 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Josephson Neil CENTRAL INDEX KEY: 0001864141 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38068 FILM NUMBER: 22734887 MAIL ADDRESS: STREET 1: 1385 WEST 8TH AVENUE, SUITE 540 CITY: VANCOUVER STATE: A1 ZIP: V6H 3V9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zymeworks Inc. CENTRAL INDEX KEY: 0001403752 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 800 - 114 EAST 4TH AVENUE CITY: Vancouver STATE: A1 ZIP: V5T 1G4 BUSINESS PHONE: (604) 678-1388 MAIL ADDRESS: STREET 1: SUITE 800 - 114 EAST 4TH AVENUE CITY: Vancouver STATE: A1 ZIP: V5T 1G4 FORMER COMPANY: FORMER CONFORMED NAME: Zymeworks Inc DATE OF NAME CHANGE: 20070620 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-10 0 0001403752 Zymeworks Inc. ZYME 0001864141 Josephson Neil C/O ZYMEWORKS INC. 114 EAST 4TH AVENUE, SUITE 800 VANCOUVER A1 V5T 1G4 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Medical Officer Common Shares 2022-03-10 4 M 0 729 0.00 A 7848 D Common Shares 2022-03-10 4 M 0 1666 0.00 A 9514 D Restricted Stock Unit 2022-03-10 4 M 0 729 0.00 D Common Shares 729 730 D Restricted Stock Unit 2022-03-10 4 M 0 1666 0.00 D Common Shares 1666 3334 D Represents common shares issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020. Represents common shares issued upon vesting of one third of the RSUs granted on March 10, 2021. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021. The RSUs were granted on March 10, 2021 and vest in three equal annual instalments beginning on March 10, 2022. /s/ Daniel Dex, Attorney-in-Fact 2022-03-11